Cook Medical announced that findings from the VIVO clinical study of the company’s Zilver Vena venous self-expanding sten ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

The 24-month outcomes from the VIVID clinical trial, which evaluated the safety and efficacy of the Duo venous stent system (Ro ...

DVT needs to be more accurately categorized on an anatomical basis, and for a variety of reasons, the area of most importance is the iliofemoral region. The rationale for active, rather than ...

J Vasc Surg 1999; 30:491-8. Passman MA, Farber MA, Marston WA, Criado E, Burnham SJ, Keagy BA. Descending thoracic aorta to iliofemoral artery bypass: A role for primary revascularization for ...

When treated with anticoagulant alone, patients with iliofemoral DVT continue to have high incidence of chronic painful edema (75%) and venous claudication (40%) [4] - ultrasound-assisted (EKOS ...